Populationsbaserede farmakokinetiske forsøg har vurderet dabigatrans farmakokinetik efter gentagne doser til patienter (op til 88 år).
Population-based pharmacokinetic studies have evaluated the pharmacokinetics of dabigatran after repeated doses in patients (up to 88 years).